BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/21/2025 6:10:15 AM | Browse: 130 | Download: 467
 |
Received |
|
2024-09-15 02:52 |
|
Peer-Review Started |
|
2024-09-15 02:52 |
|
First Decision by Editorial Office Director |
|
2024-09-30 10:41 |
|
Return for Revision |
|
2024-09-30 10:41 |
|
Revised |
|
2024-10-15 05:43 |
|
Publication Fee Transferred |
|
2025-01-16 12:02 |
|
Second Decision by Editor |
|
2024-12-30 02:28 |
|
Second Decision by Editor-in-Chief |
|
2025-01-03 07:58 |
|
Final Decision by Editorial Office Director |
|
2025-01-15 07:24 |
|
Articles in Press |
|
2025-01-15 07:24 |
|
Edit the Manuscript by Language Editor |
|
2025-02-22 19:41 |
|
Typeset the Manuscript |
|
2025-03-13 08:55 |
|
Publish the Manuscript Online |
|
2025-03-21 06:10 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Basic Study |
| Article Title |
MiR-21-5p-enriched exosomes from hiPSC-derived cardiomyocytes exhibit superior cardiac repair efficacy compared to hiPSC-derived exosomes in a murine MI model
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Jun Jin, Rong-Hua Liu, Jin-Yan Chen, Kun Wang, Jun-Yong Han, Dao-Shun Nie, Yu-Qing Gong, Bin Lin and Guo-Xing Weng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Nonprofit Research Institutes Foundation of Fujian Province, China |
2021R1012005, 2021R1012003 |
|
| Corresponding Author |
Jing-Jun Jin, Fujian Key Laboratory of Medical Analysis, Fujian Academy of Medical Sciences, No. 7 Wusi Road, Fuzhou 350001, Fujian Province, China. yolanda_jin19@hotmail.com |
| Key Words |
Human-induced pluripotent stem cell; Human-induced pluripotent stem cell-derived cardiomyocytes; Myocardial infarction; Exosomes; MiR-21-5P; Apoptosis |
| Core Tip |
This study explores human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their exosomes for myocardial infarction repair. Despite issues with hiPSCs-derived cardiomyocytes, exosomes are promising due to low immunogenicity. By differentiating hiPSCs and characterizing, it’s found they improve cardiac function in a murine myocardial infarction model. HiPSC-derived cardiomyocytes exosomes are superior, with miR-21-5p key. Thus, they may be a strong agent for myocardial repair and inspire further research on exosome treatment for heart disease. |
| Publish Date |
2025-03-21 06:10 |
| Citation |
Jin JJ, Liu RH, Chen JY, Wang K, Han JY, Nie DS, Gong YQ, Lin B, Weng GX. MiR-21-5p-enriched exosomes from hiPSC-derived cardiomyocytes exhibit superior cardiac repair efficacy compared to hiPSC-derived exosomes in a murine MI model. World J Stem Cells 2025; 17(3): 101454 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i3/101454.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i3.101454 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
